Barry Shea is a Respiratory physician affiliated with Harvard University. OpenAlex indexes 69 publications with 4,613 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Boston, MA 021142621
Telephone
617-726-1721Provider last certified this registry record 12 Feb 2026.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year202411 payments
- Radius Health, Inc.Program year20232 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2011–2020 per NIH RePORTER. The latest:
- Fibrin-PET Imaging to Detect Aging Associated Lung Injury in Idiopathic Pulmonary Fibrosis
Massachusetts General Hospital
FY2020$158,405R21AG065602 - The Role of Sphingosine 1-Phosphate in Lung Injury and Fibrosis
Massachusetts General Hospital
FY2014$137,160K08HL105656 - The Role of Sphingosine 1-Phosphate in Lung Injury and Fibrosis
Massachusetts General Hospital
FY2013$137,160K08HL105656
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicting response to immunosuppression in non-IPF interstitial lung diseases: can molecular endotyping lead the way?
American Journal of Respiratory and Critical Care Medicine
2026 - Clonal Hematopoiesis Instructs Maladaptive Tissue Repair to Promote Fibrosis
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Low forced vital capacity is associated with poor prognosis in physiologically stable non-IPF interstitial lung disease
European Respiratory Journal
2025 - Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD
Respiratory Medicine and Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”